SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Inhibitex, Inc. (INHX) -- Ignore unavailable to you. Want to Upgrade?


To: Ian@SI who wrote (1)1/6/2005 9:35:34 PM
From: tuck  Read Replies (1) | Respond to of 7
 
Contrary to many Wave II IPOs, there has been buying of the stock, mostly by new institutions, but also by an employee or two.

finance.yahoo.com

Wonder how the various antibiotics stack up against each other.

Message 20922363

There was Telavancin, here is Veronate . . . getting crowded, said rkrw. Right!

In left field, but a contender, is NABI's staphVAX.

Cheers, Tuck